The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
13150
Product Theater: The robust clinical data behind the ENTYVIO (vedolizumab) Pen
Date
May 5, 2025
Society: DDW
Review ENTYVIO's mechanism of action, explore the clinical profile of the ENTYVIO Pen, and discover which support resources are available for patients getting started on the ENTYVIO Pen (after at least 2 intravenous infusions).
Supported by: Takeda Pharmaceuticals U.S.A., Inc.
